HIGHLIGHTS
- who: August and collaborators from the Kohat University of Science and, India have published the article: Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview, in the Journal: (JOURNAL)
- what: The aim of PC treatment is to enhance the efficiency of drug delivery and minimize drug resistance.
- how: Their results showed that GEM-HSA-NPs was more effective at slowing pancreatic cell proliferation and triggering apoptosis in comparison to free GEM alone without any increase in toxicity as shown in_vivo studies.
- future: Future studies utilizing nanotechnology . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.